Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Obesity

Health: Research shows diet has a significant impact on risk of Alzheimer's disease

Alzheimer's disease rates rise in these countries as they make the nutrition transition to the Western diet. Read further on Dynamite News:

Dynamite News

Which Weight Loss Drug Is Best And Safest? Here’s What Sets Them Apart

Earlier this month, the FDA approved Eli Lilly's Zepbound, a drug similar to its diabetes drug Mounjaro but specifically advertised for weight loss.

Inverse

Cost of people being overweight in UK now £98bn, study finds

Estimate includes £63bn cost to people affected, £19bn cost to NHS and £15bn cost to society

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Roche Stock Rises On $3.1 Billion Deal For Obesity Drugmaker

Roche said it will spend up to $3.1 billion to acquire Carmot Therapeutics, a biotech firm developing obesity drugs.

Investors Business Daily

Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

International Business Times

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

The Independent UK

Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options

Zepbound is expected to be available in the U.S. by the end of the year.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Overweight Teens Face Higher Cancer Risk, Study Shows

Obesity in adolescence linked to up to 17 different cancers, raising concerns about long-term health consequences.

Zenger

Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs

Weight-loss drug Wegovy faces high demand, limited supply, and tricky health care systems to navigate.

Fortune

Ultra-Processed Food-Cancer Link: Study Says Higher Risk Not Just Due To Obesity

The study has found that eating 10% more ultra-processed food raises the risk of head and neck cancer by 23% and the risk of esophageal adenocarcinoma by 24%.

Medical Daily

No more Thanksgiving 'food orgy'? New obesity medications change how users think of holiday meals

Holiday meals may be changing for millions of Americans struggling with obesity and taking a new generation of weight-loss drugs

The Independent UK

Revealed: obesity jab maker discussed targeting benefit claimants with UK government

Drug firm Novo Nordisk proposed singling out those most likely to return to work with its weight-loss injection

The Guardian - UK

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Barchart

'As bad as 15 cigarettes a day': WHO declares loneliness a global health concern

The effects of loneliness can be greater than obesity and smoking

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

LiveScience

Here's what happens when cats get too fat (it involves acidic poop)

Obesity is wreaking havoc on cats' digestive systems, causing "significant changes" in their gut microbial compositions and giving them highly acidic poop.

The Conversation

Mounjaro has been authorised for weight loss in the UK – here's how it compares to Wegovy

The type 2 diabetes drug tirzepatide (better known by its brand name Mounjaro) has recently been authorised by the UK’s medicines regulation authority for use in weight loss and weight management. The decision was made on the same day the US Food and Drug Administration (FDA) approved a version of…

The Hindu

Initiative launched to assist college students in Chennai stay healthy and in shape

M.V. Diabetes & M. Viswanathan Diabetes Research Centre launched Chennai Slim & Fit 2.0 to educate college students on healthy lifestyle & prevent obesity. 6,000 school students were followed in 2007, with findings published in 2013. Nina Reddy, Joint MD of Savera Hotel, urged people to look after themselves &…

The Conversation

Insecure renting ages you faster than owning a home, unemployment or obesity. Better housing policy can change this

People’s experiences of private rental housing are linked to faster biological ageing, our recent research finds.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients

The Hindu

ICMR-NIN scientists find alarming obesity levels in Telangana and Andhra Pradesh

ICMR-NIN study finds alarming obesity rates in Hyderabad & Telugu States; 47.7% urban adults in Telangana & 46.7% rural adults in AP obese. Over 11% urban & 6% rural adults suffer from hypertension; 5% in both regions have diabetes. Adults aged 40-59 & those engaged in clerical/skilled/semi-skilled occupations have higher…

The Independent UK

FDA approves new weight loss drug

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug

The Guardian - UK

AstraZeneca makes big push into weight-loss market with obesity pill deal

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

WEKU

FDA approves Zepbound, a new obesity drug that will take on Wegovy

Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.

The Independent UK

Diabetes drug authorised for weight management and loss – MHRA

Obese and overweight adults could have access to Tirzepatide – also known as Mounjaro – if it receives further approval.

The Independent UK

FDA approves new version of diabetes drug Mounjaro for weight loss

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug

1 … 26 27 28 29

People

Lars Fruergaard Jørgensen

17 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

the Department of Health

97 stories

Wegovy

56 stories

Eli Lilly and Company

53 stories

the US Food and Drug Administration

42 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.